ヘルスケアBPOの世界市場予測（～2022年）...市場調査レポートについてご紹介

TABLE OF CONTENTS

1 INTRODUCTION 17
1.1 OBJECTIVES OF THE STUDY 17
1.2 MARKET DEFINITION 17
1.2.1 MARKET COVERED 18
1.2.2 YEARS CONSIDERED FOR THE STUDY 18
1.3 CURRENCY 19
1.4 LIMITATIONS 19
1.5 STAKEHOLDERS 19

2 RESEARCH METHODOLOGY 20
2.1 RESEARCH DATA 20
2.1.1 SECONDARY DATA 21
2.1.1.1 Key data from secondary sources 21
2.1.2 PRIMARY DATA 22
2.1.2.1 Key data from primary sources 22
2.1.2.2 Breakdown of primaries 23
2.1.2.3 Key industry insights 23
2.2 MARKET SIZE ESTIMATION 24
2.3 MARKET BREAKDOWN AND DATA TRAINGULATION 26
2.3.1 ASSUMPTIONS FOR THE STUDY 27

3 EXECUTIVE SUMMARY 28

4 PREMIUM INSIGHTS 33
4.1 HEALTHCARE BPO: MARKET OVERVIEW 33
4.2 US HEALTHCARE BPO MARKET, BY PROVIDER & PHARMACEUTICAL SERVICES (2016) 34
4.3 HEALTHCARE BPO PATIENT CARE SERVICES MARKET, BY TYPE,
2017 VS. 2022 (USD BILLION) 34
4.4 HEALTHCARE BPO MARKET, BY DESTINATION GEOGRAPHY (2017) 35

5 MARKET OVERVIEW 36
5.1 INTRODUCTION 36
5.1.1 DRIVERS: PAYER SERVICES MARKET 38
5.1.1.1 Regulatory changes in the US with the implementation of PPACA 38
5.1.1.2 Pressure to reduce rising healthcare costs 38
5.1.1.3 Demand for niche services 38
 
5.1.2 DRIVERS: PROVIDER SERVICES MARKET 39
5.1.2.1 Shift to ICD-10 coding standards and upcoming ICD-11 39
5.1.2.2 Loss of revenue due to billing errors 39
5.1.2.3 Increasing consolidation in the healthcare industry 39
5.1.2.4 Need for structured processes, documentation 40
5.1.3 DRIVERS IN THE PHARMACEUTICAL SERVICE MARKET 40
5.1.3.1 Patent cliff 40
5.1.3.2 Increasing R&D costs and strict regulations 40
5.1.4 RESTRAINTS 41
5.1.4.1 Hidden Costs of Outsourcing 41
5.1.4.2 Fear of Losing Visibility and Control over the Business Process 41
5.1.5 CHALLENGES: PROVIDER SERVICES MARKET 41
5.1.5.1 Dearth of skilled workforce 41
5.1.5.2 Competition from hospital management companies 42
5.2 OUTSOURCING APPROACHES 42
5.2.1 BUNDLED SERVICES 42
5.2.2 FEE FOR SERVICE 42
5.2.3 FLEXIBLE CONTRACTS 43
5.2.4 BEST-SHORE 43
5.3 OUTSOURCING MODELS 43
5.3.1 MULTISOURCING 43
5.3.2 CAPTIVE CENTER 44
5.3.3 HYBRID DELIVERY MODEL 45
5.3.4 PREFERRED PROVIDER 45
5.3.5 STRATEGIC PARTNERSHIP 45
5.3.6 GLOBAL DELIVERY MODEL 46

6 HEALTHCARE BPO MARKET, BY PROVIDER SERVICE 47
6.1 INTRODUCTION 48
6.2 REVENUE CYCLE MANAGEMENT 50
6.3 PATIENT ENROLLMENT 52
6.4 PATIENT CARE 53
6.4.1 MEDICAL TRANSCRIPTION 54
6.4.2 DEVICE MONITORING 56
6.4.3 MEDICAL IMAGING 58
 

7 HEALTHCARE BPO MARKET, BY PAYER SERVICE 60
7.1 INTRODUCTION 61
7.2 CLAIMS MANAGEMENT SERVICES 63
7.2.1 CLAIMS ADJUDICATION SERVICES 65
7.2.2 CLAIMS SETTLEMENT SERVICES 66
7.2.3 INFORMATION MANAGEMENT SERVICES 67
7.2.4 CLAIMS REPRICING 68
7.2.5 CLAIMS INVESTIGATION SERVICES 70
7.2.6 CLAIMS INDEXING SERVICES 71
7.2.7 FRAUD DETECTION AND MANAGEMENT 72
7.3 INTEGRATED FRONT-END SERVICES AND BACK-OFFICE OPERATIONS 74
7.4 MEMBER MANAGEMENT SERVICES 75
7.5 PRODUCT DEVELOPMENT AND BUSINESS ACQUISITION SERVICES 77
7.6 PROVIDER MANAGEMENT SERVICES 78
7.7 CARE MANAGEMENT 80
7.8 BILLING AND ACCOUNTS MANAGEMENT SERVICES 81
7.9 HR SERVICES 82

8 HEALTHCARE BPO MARKET, BY PHARMACEUTICAL SERVICE 84
8.1 INTRODUCTION 85
8.1.1 RESEARCH & DEVELOPMENT 87
8.1.2 MANUFACTURING 88
8.1.3 NON-CLINICAL SERVICES 90
8.1.3.1 Supply chain management & logistics 91
8.1.3.2 Sales and marketing services 92
8.1.3.2.1 Analytics 94
8.1.3.2.2 Marketing services 96
8.1.3.2.3 Research 97
8.1.3.2.4 Forecasting 98
8.1.3.2.5 Performance reporting 99
8.1.3.3 Other non-clinical functions 101

9 GEOGRAPHIC ANALYSIS 103
9.1 SOURCE GEOGRAPHY 104
9.1.1 US 105
9.1.2 EUROPE 109
9.1.3 ROW 114
 
9.2 DESTINATION GEOGRAPHY 117
9.2.1 INDIA 117
9.2.2 US 122
9.2.3 EUROPE 126
9.2.4 CHINA 129
9.2.5 LATIN AMERICA 133
9.2.6 PHILIPPINES 136
9.2.7 MIDDLE EAST 139
9.2.8 ROW 143

10 COMPANY PROFILES 147
(BUSINESS OVERVIEW, PRODUCTS OFFERED, STRENGTH OF PRODUCT PORTFOLIO, BUSINESS STRATEGY EXCELLENCE, RECENT DEVELOPMENTS.)*
10.1 ACCENTURE 147
10.2 COGNIZANT TECHNOLOGY SOLUTIONS 151
10.3 FIRSTSOURCE SOLUTIONS. 154
10.4 GEBBS HEALTHCARE SOLUTIONS, 157
10.5 GENPACT 159
10.6 IBM 162
10.7 INFOSYS 165
10.8 INVENSIS TECHNOLOGIES. 168
10.9 LONZA 170
10.10 OMEGA HEALTHCARE 173
10.11 QUINTILES IMS HOLDINGS, 175
10.12 R1 RCM 178
10.13 TATA CONSULTANCY SERVICES 180
10.14 WNS (HOLDINGS) 183
10.15 XEROX 186
*Details on Business Overview, Strength of Product Portfolio, Business Strategy Excellence, Recent Developments, Key relationships might not be captured in case of unlisted companies.

11 APPENDIX 189
11.1 INSIGHTS OF INDUSTRY EXPERTS 189
11.2 DISCUSSION GUIDE 190
11.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 196
11.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 198
11.5 AVAILABLE CUSTOMIZATIONS 200
11.6 RELATED REPORTS 200
11.7 AUTHOR DETAILS 201